What the business is, and whether it's a good one at a fair price.
A IT - Software company listed on BSE, reporting revenue of ₹17 Cr over the trailing twelve months.
Measured from the filed financials, judged against its Computers - Software & Consulting peers · as of FY25 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from Shradha AI Technologies Limite's filed financials and exchange disclosures
Shradha AI Technologies Limite is a IT - Software company listed on BSE.
Yes. Over the trailing twelve months Shradha AI Technologies Limite reported a net profit of ₹9 Cr on revenue of ₹17 Cr.
Yes. The dividend yield is 1.30% at the current price. It paid out 19% of its profit as dividend in FY25.
Effectively yes. It holds ₹6 Cr more cash than debt. Debt stands at 0.00× equity.
On trailing P/E, Shradha AI Technologies Limite ranks 29 of 71 in Computers - Software & Consulting — cheaper than 60% of them, against an industry median of 16.6×. This is a position, not a valuation judgement.
On a typical session Shradha AI Technologies Limite moves 1.47% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by Shradha AI Technologies Limite appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
